Euroafrica Digital Ventures AB publicerade idag den 24 februari 2022 sin delårsrapport för fjärde kv...
Redeye’s preliminary revisions suggest reduced short-term margin assumptions while leaving our long-...
AcouSort publicerade idag den 24 februari 2022 sin bokslutskommuniké för år 2021 samt delårsrapport ...
Redeye comments on 2cureX’s Q4’21 report. It has been an eventful quarter for 2cureX, including the ...
Redeye maintains its positive view and valuation of LIDDS after the report today.
Redeye comments on Cantargia's Q4 report.
Abelco publicerade den 24 februari 2021 bolagets delårsrapport för fjärde kvartalet 2021.
Gold Town Games publicerade idag den 24 februari sin delårsrapport för fjärde kvartalet 2021.
Ökade volymer inom medicinteknik Corline presenterade nyligen sin Q4-rapport som överträffade våra f...
Fortsatt förbättring av marginalen Sensys Gatso redovisade en omsättning på 507 mkr (455) och EBIT 4...
I dag offentliggjorde Pharmiva sin delårsrapport för det fjärde kvartalet 2021.
Redeye provides a short comment on the Q4 report published by Asarina Pharma earlier today.
Tangiamo publicerade idag den 24 februari 2022 bolagets delårsrapport för årets fjärde kvartal.
Redeye comments on CLS’s Q4’21 report. We continue to see an interesting year ahead and reiterate ou...
Redeye notes a relatively decent quarter for AroCell, which is currently trading under our Bear Case...
Redeye provides a comment on the Q4 report published by Alzinova earlier this morning.
Redeye leaves its comment on InDex following the announcement of its year-end report.
Redeye thinks it's likely that Sivers will make a rights issue in Q3.
Redeye takes a more positive stance towards Hexatronic following an excellent Q4 report.
Redeye raises its Base Case and long-term forecasts slightly for Hanza following an overall strong Q...
